The Human Rabies Vaccine Market holds tremendous potential for influencing public health outcomes, as rabies remains one of the deadliest infectious diseases worldwide. With a market projected to achieve a size of USD 1.312 billion by 2035, the urgency to ensure comprehensive vaccine distribution is more critical than ever. A 6.98% CAGR reflects the anticipated growth of this sector, driven...